Inventor profile of:

Hakon Hakonarson

City:

Malvern, Pennsylvania

Country:

United States

Published Applications:

85

Last publication date:

2026-03-19

Top Assignees for applications by Hakon Hakonarson

The entities that hold a legal rights for patent applications filed by inventor Hakonarson Hakon:

Recent patent applications by Hakonarson Hakon

Hakon Hakonarson from Malvern, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19
US20260076953A1
Human necessities

METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS

#2 | 2026-03-12
US20260071276A1
Chemistry; metallurgy

GPCR LATROPHILIN-3 AS BIOMARKER FOR DETECTING INCREASED RISK FOR MILD BRAIN INJURY AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME

#3 | 2026-01-22
US20260022420A1
Chemistry; metallurgy

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#4 | 2025-10-02
US20250306031A1
Physics

COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES

#5 | 2025-04-24
US20250129423A1
Chemistry; metallurgy

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#6 | 2025-04-24
US20250127771A1
Human necessities

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

#7 | 2025-04-17
US20250120962A1
Human necessities

NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME

#8 | 2024-06-13
US20240189295A1
Human necessities

NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER

#9 | 2024-05-16
US20240156801A1
Human necessities

METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS

#10 | 2024-03-28
US20240100036A1
Human necessities

METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER

#11 | 2024-03-07
US20240075022A1
Human necessities

METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER

#12 | 2023-12-21
US20230407399A1
Chemistry; metallurgy

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#13 | 2023-11-09
US20230357849A1
Chemistry; metallurgy

GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE

#14 | 2023-10-05
US20230313304A1
Chemistry; metallurgy

Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)

#15 | 2023-09-28
US20230304094A1
Chemistry; metallurgy

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#16 | 2023-09-28
US20230304018A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS

#17 | 2023-02-16
US20230048706A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS

#18 | 2022-11-03
US20220349008A1
Chemistry; metallurgy

NOVEL GENETIC MARKERS FOR POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME

#19 | 2022-11-03
US20220347255A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF HEREDITARY CYSTATIN C AMYLOID ANGIOPATHY (HCCAA) AND OTHER NEURODEGENERATIVE DISORDERS ASSOCIATED WITH ABERRANT AMYLOID DEPOSITS

#20 | 2022-10-27
US20220339156A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS

#21 | 2022-10-06
US20220316008A1
Chemistry; metallurgy

COMPOSITIONS COMPRISING RARE GENETIC SEQUENCE VARIANTS ASSOCIATED WITH PULMONARY FUNCTION AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF ASTHMA IN AFRICAN AMERICAN PATIENTS

#22 | 2022-09-22
US20220296582A1
Human necessities

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

#23 | 2022-04-21
US20220117954A1
Human necessities

Methods of diagnosing and treating anxiety disorder

#24 | 2022-04-21
US20220117953A1
Human necessities

Methods of diagnosing and treating conduct disorder

#25 | 2022-04-14
US20220112558A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS

#26 | 2022-02-24
US20220056529A1
Chemistry; metallurgy

IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE LOCI AND METHODS FOR USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#27 | 2021-09-02
US20210267958A1
Human necessities

Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder

#28 | 2021-08-19
US20210254160A1
Chemistry; metallurgy

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#29 | 2021-08-19
US20210251973A1
Human necessities

NOVEL TOPICAL FORMULATION FOR INTRADERMAL APPLICATION AND USES THEREOF

#30 | 2021-07-08
US20210205288A1
Human necessities

Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome

#31 | 2021-05-13
US20210137909A1
Human necessities

Methods of diagnosing and treating ADHD in biomarker positive subjects

#32 | 2020-12-10
US20200385739A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS

#33 | 2020-10-15
US20200323944A1
Human necessities

Compositions and methods for treatment of hereditary cystatin C amyloid angiopathy (HCCAA) and other neurodegenerative disorder associated with aberrant amyloid deposits

#34 | 2020-10-01
US20200306237A1
Human necessities

Methods of diagnosing and treating Tourette syndrome

#35 | 2020-07-02
US20200208220A1
Chemistry; metallurgy

Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)

#36 | 2020-03-12
US20200080152A1
Chemistry; metallurgy

Methods for use in the diagnosis of autoimmune diseases

#37 | 2020-02-20
US20200056238A1
Chemistry; metallurgy

Compositions and methods for the diagnosis and treatment of lymphatic system disorders

#38 | 2019-12-12
US20190376127A1
Chemistry; metallurgy

Compositions and methods targeting the Th2 pathway for the treatment of asthma

#39 | 2019-10-10
US20190309366A1
Chemistry; metallurgy

CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same

#40 | 2019-10-03
US20190298706A1
Human necessities

Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder

#41 | 2019-07-18
US20190218612A1
Chemistry; metallurgy

Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same

#42 | 2019-05-23
US20190153523A1
Chemistry; metallurgy

IDENTIFICATION OF NOVEL LOCI IN ASTHMA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA

#43 | 2019-03-07
US20190070247A1
Human necessities

Compositions and Methods for Treatment of Hereditary Cystatin C Amyloid Angiopathy (HCCAA) and Other Neurodegenerative Disorders Associated with Aberrant Amyloid Deposits

#44 | 2018-09-27
US20180274032A1
Chemistry; metallurgy

Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets

#45 | 2018-08-09
US20180223373A1
Chemistry; metallurgy

Mutations in and as causes of autosomal dominant infantile myofibromatosis

#46 | 2018-05-31
US20180148786A1
Chemistry; metallurgy

GENETIC ALTERATIONS ASSOCIATED WITH AUTISM AND THE AUTISTIC PHENOTYPE AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF AUTISM

#47 | 2018-05-10
US20180127824A1
Chemistry; metallurgy

Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis

#48 | 2018-04-26
US20180110767A1
Human necessities

Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome

#49 | 2017-04-20
US20170105985A1
Human necessities

Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome

#50 | 2017-03-30
US20170087141A1
Human necessities

Methods of diagnosing and treating anxiety disorder

#51 | 2017-03-30
US20170087140A1
Human necessities

Methods of diagnosing and treating conduct disorder

#52 | 2017-03-30
US20170087139A1
Human necessities

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

#53 | 2017-03-23
US20170083664A1
Physics

Methods of diagnosing and treating autism

#54 | 2017-02-23
US20170051352A1
Chemistry; metallurgy

Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene

#55 | 2017-02-23
US20170051351A1
Chemistry; metallurgy

Methods for use in combination for the treatment and diagnosis of autoimmune diseases

#56 | 2017-02-16
US20170044611A1
Chemistry; metallurgy

Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#57 | 2017-01-12
US20170009296A1
Chemistry; metallurgy

Methods to diagnose and treat attention-deficit, hyperactivity disorder (ADHD)

#58 | 2016-12-01
US20160348177A1
Chemistry; metallurgy

CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same

#59 | 2016-09-15
US20160265053A1
Chemistry; metallurgy

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#60 | 2016-08-25
US20160244831A9
Chemistry; metallurgy

Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism

#61 | 2016-03-24
US20160083799A1
Chemistry; metallurgy

Mutations in PDGFRB and NOTCH3 as causes of autosomal dominant infantile myofibromatosis

#62 | 2016-02-18
US20160046996A1
Chemistry; metallurgy

Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same

#63 | 2016-02-04
US20160032390A1
Chemistry; metallurgy

Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof

#64 | 2015-10-22
US20150299793A1
Chemistry; metallurgy

Genetic alterations on chromosomes 21Q, 6Q and 15Q and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#65 | 2015-02-19
US20150051114A1
Chemistry; metallurgy

GENETIC VARIANTS UNDERLYING HUMAN COGNITION AND METHODS OF USE THEREOF AS DIAGNOSTIC AND THERAPEUTIC TARGETS

#66 | 2015-01-22
US20150023984A1
Chemistry; metallurgy

Genetic alterations associated with type I diabetes and methods for use thereof for diagnosis and treatment

#67 | 2014-10-23
US20140315992A1
Chemistry; metallurgy

Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism

#68 | 2014-10-09
US20140303243A1
Chemistry; metallurgy

Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism

#69 | 2014-09-11
US20140255387A1
Chemistry; metallurgy

Genetic alterations and methods of use thereof for the diagnosis and treatment of type I diabetes

#70 | 2013-11-28
US20130315931A1
Chemistry; metallurgy

CXCR4 as a Susceptibility Locus in Juvenile Idiopathic Arthritis (JIA) and Methods of Use Thereof for the Treatment and Diagnosis of the Same

#71 | 2013-11-28
US20130315858A1
Chemistry; metallurgy

Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same

#72 | 2013-08-08
US20130203814A1
Chemistry; metallurgy

Association of Rare Recurrent Genetic Variations to Attention-Deficit, Hyperactivity Disorder (ADHD) and Methods of Use Thereof for the Diagnosis and Treatment of the Same

#73 | 2013-02-07
US20130035240A1
Chemistry; metallurgy

Markers for Obesity and Methods of Use Thereof

#74 | 2012-12-06
US20120309639A1
Chemistry; metallurgy

Compositions and Methods for Diagnosing Genome Related Diseases and Disorders

#75 | 2012-04-19
US20120095074A1
Chemistry; metallurgy

Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#76 | 2011-12-22
US20110311512A1
Chemistry; metallurgy

Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets

#77 | 2011-11-03
US20110269688A1
Chemistry; metallurgy

Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same

#78 | 2011-10-06
US20110243922A1
Chemistry; metallurgy

Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment

#79 | 2011-09-29
US20110236370A1
Chemistry; metallurgy

Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes

#80 | 2011-08-25
US20110207124A1
Chemistry; metallurgy

Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism

#81 | 2011-08-18
US20110200583A1
Chemistry; metallurgy

Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods

#82 | 2011-07-21
US20110177502A1
Chemistry; metallurgy

IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

#83 | 2010-08-26
US20100216863A1
Human necessities

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

#84 | 2009-01-29
US20090030037A1
Human necessities

Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy

#85 | 2008-11-27
US20080293750A1
Chemistry; metallurgy

Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment

InventorID:

79674 ⎘